# DOTA chelation

Source: https://nuclide.cc/technologies/dota-chelation/  
Nuclide record `dota-chelation` (Technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

DOTA is a small ring-shaped molecule that grips a radioactive metal atom tightly inside its cage, so the metal stays attached to the drug instead of drifting off into the body.

## Summary

DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) is a twelve-membered tetraaza macrocycle with four pendant carboxylate arms that together provide an octadentate (four nitrogen, four oxygen) cage for trivalent and some divalent radiometals. Complex formation proceeds through a diprotonated intermediate in which the metal sits outside the macrocyclic cavity, coordinated only to the four acetate arms; the rate-determining step is loss of the last ring-nitrogen proton, which lets the metal drop into the fully encapsulated, kinetically inert 'in-cage' geometry. Once formed at room temperature the complex does not revert, but formation itself is slow and usually needs heating (often 80-95°C) and, for large ions such as Ac3+, is inefficient because DOTA's cavity is sized for smaller lanthanide-like ions.

This chemistry underpins the majority of clinically used radiometal agents: 68Ga- and 177Lu-DOTATATE/DOTATOC, 90Y- and 177Lu-DOTA-conjugated peptides, and experimental 225Ac and 213Bi constructs. Its main practical strengths are extreme in vivo kinetic inertness (once formed, the metal essentially never leaves under physiological conditions) and a very large body of manufacturing and regulatory precedent. Its main limitations are the elevated temperature and time needed for labelling, which complicates heat-sensitive biomolecules such as antibodies, and its comparatively poor match to large ions like Ac3+, which has driven the search for alternative chelators such as macropa.

## Fields

- Kind: Technology
- Last checked: 2026-09-22
- Also known as: DOTA; 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
- Tags: chemistry; chelator
- Principle: A twelve-membered tetraaza macrocycle with four pendant carboxylate arms wraps around a metal ion, first binding it loosely outside the ring cavity, then, as the last ring-nitrogen proton is lost, letting the metal drop fully inside the cage to form an octadentate, kinetically inert complex that does not release the metal under physiological conditions.
- Since: 1980s (macrocyclic chelator chemistry); adapted to radiometals through the 1990s-2000s

## Sources

- Price & Orvig, Chem Soc Rev 2014: Matching chelators to radiometals for radiopharmaceuticals: https://doi.org/10.1039/C3CS60304K
- One ring to bind them all? Review on DOTA complexes with medically relevant radiometals: https://www.research.unipd.it/handle/11577/3611078
- Mechanism and energetics of 90Y-DOTA complexation (J. Am. Chem. Soc. 1999): https://pubs.acs.org/doi/10.1021/ja983706q
- Metal Chelating Agents for Medicinal Radionuclides (UBC open thesis, background on DOTA kinetics): https://open.library.ubc.ca/media/stream/pdf/24/1.0392203/4

## Connected records

- technologies: [Albumin-binder ligands](https://nuclide.cc/technologies/albumin-binder-ligands/), [Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)](https://nuclide.cc/technologies/cyclotron-isotope-production/), [Macropa chelation](https://nuclide.cc/technologies/macropa-chelation/), [Peptide receptor radionuclide therapy (PRRT)](https://nuclide.cc/technologies/prrt/), [Radiohybrid (rh) chemistry](https://nuclide.cc/technologies/radiohybrid-chemistry/), [Radioligand dosimetry](https://nuclide.cc/technologies/radioligand-dosimetry/), [Radiopharmacy and cyclotron networks](https://nuclide.cc/technologies/radiopharmacy-network/), [Sarcophagine chelation](https://nuclide.cc/technologies/sarcophagine-chelation/), [Targeted alpha therapy](https://nuclide.cc/technologies/targeted-alpha-therapy/)
- isotopes: [Actinium-225](https://nuclide.cc/isotopes/ac-225/), [Bismuth-213](https://nuclide.cc/isotopes/bi-213/), [Gallium-68](https://nuclide.cc/isotopes/ga-68/), [Lutetium-177](https://nuclide.cc/isotopes/lu-177/), [Yttrium-90](https://nuclide.cc/isotopes/y-90/)

---
JSON: https://nuclide.cc/api/v1/entities/dota-chelation.json